Adults who read about cord blood banking often ask whether they missed their only chance to store their own cells. This Cord Blood vs Adipose guide explains what cord blood banking is, why it was only an option at birth, and what adult adipose tissue banking is and is not. It makes no claim that one option is better than the other.
TLDR Cord blood is collected from the umbilical cord at birth and holds blood forming cells, and nine cord blood products hold FDA licenses, all for unrelated donor transplantation. Adipose tissue is removed from an adult’s own body and holds a different cell population that is studied for different things, and no adipose-derived product has FDA approval. Banking adipose tissue preserves your own tissue and does not guarantee eligibility, access, or clinical benefit from any future therapy.
Important Disclaimer: Save My Fat does not provide FDA-approved treatments or cures for any disease, including blood cancers and immune disorders. Banking adipose tissue today does not guarantee eligibility, access, or clinical benefit from any future therapy, clinical trial, or medical program. No adipose-derived stem cell product currently has FDA approval for any condition. All content is for educational purposes only and does not constitute medical advice. Patients must consult their own licensed healthcare professionals regarding all medical decisions.
You are an adult, and a friend just banked cord blood for a newborn. The brochure described cells stored at birth for possible later use, and the obvious question followed you home. Did you miss your chance?
The short answer is that cord blood banking was a one time option at birth, and adult adipose tissue banking is a different thing with a different cell population and a different regulatory picture. The two are often described as if one were the adult version of the other. They are not.
What Is Cord Blood Banking?
Cord blood banking is the collection of blood from the umbilical cord at birth and its storage for possible later use, as FDA describes on its cord blood page for consumers. FDA explains that cord blood contains hematopoietic progenitor cells, meaning blood forming stem cells, and that these cells are used in transplants for patients with blood cancers and some inherited metabolic and immune disorders.
FDA describes two kinds of banks. A public bank stores donated cord blood for anyone who matches. A private bank stores it for the child it came from, or for first or second degree relatives. FDA also notes that a child’s own cord blood may not be recommended for that child’s own heritable disease.
The regulatory line runs between related and unrelated use. Cord blood stored for private use needs no FDA approval before use, but the bank must register and list with FDA, screen and test donors, and follow current good tissue practice. Cord blood for unrelated recipients must be licensed under a biologics license application (BLA) or used under an investigational new drug application (IND). Because collection happens at birth, an adult has no cord blood option of their own.
What Are Cord Blood Products Licensed For?
Licensed cord blood products are approved for unrelated donor hematopoietic progenitor cell transplantation, for hematopoietic and immunologic reconstitution in patients with inherited or acquired blood system disorders. FDA’s approved products list shows nine licensed HPC, Cord Blood products. One of them, HEMACORD, shows an initial U.S. approval of 2011 on its product page.
Four of those product pages carry identical indication wording, and the licenses cover unrelated donor use, not a child’s own stored unit. For the Cord Blood vs Adipose question, two points follow. These licenses cover blood forming cells, not mesenchymal cells, so they say nothing about the cell type studied from fat. And no adipose-derived product appears anywhere on that list.
What Is Different About Adipose Tissue?
Adipose tissue holds a different cell population from cord blood, and that population is studied for different things. Hematopoietic stem cells “are responsible for the generation of all functional haematopoietic lineages in blood,” as a 2019 review puts it (Zakrzewski 2019). Adipose research focuses instead on mesenchymal stromal cells.
Questions about what mesenchymal stromal cells are, and which surface markers define them, are among the searches that most consistently bring readers to this site. The 2006 ISCT position statement defines mesenchymal stromal cells as plastic adherent cells that express CD105, CD73 and CD90, lack CD45, CD34 and other hematopoietic markers, and differentiate to bone, cartilage and fat in the laboratory (Dominici 2006).
These cells are studied mainly for immunomodulatory and paracrine effects, meaning secreted factors, rather than blood reconstitution (Tolar 2010). That research is early stage, no adipose-derived product has FDA approval, and questions about it belong with a licensed provider. FDA approved Ryoncil on December 18, 2024 for steroid refractory acute graft versus host disease in pediatric patients 2 months and older, and its approval notice describes an allogeneic, bone marrow derived therapy. It is not adipose and not autologous, so it does not validate banked tissue, a point our birth tissue comparison also makes.
Cord Blood vs Adipose: What Applies to You as an Adult?
As an adult, cord blood banking is not available to you, because your own cord blood was either collected at birth or it was not. Adipose tissue differs in one practical way: it can be removed from your own body now and stored as autologous tissue, meaning tissue intended only for you.
Under 21 CFR 1271.90, an establishment “is not required to make a donor-eligibility determination” or to perform donor screening or testing for “cells and tissues for autologous use.” Such tissue must be prominently labeled “FOR AUTOLOGOUS USE ONLY” when stored for that purpose, and “NOT EVALUATED FOR INFECTIOUS SUBSTANCES” unless all applicable screening and testing was done. Part 1271 addresses communicable disease, not clinical value.
Banking is preservation, not treatment. Save My Fat connects patients and providers with a U.S. tissue bank; it does not collect, process, store, or treat tissue itself. Whether stored tissue ever has a use depends on FDA regulatory status at that time, physician guidance, and whether an approved or investigational pathway exists. Our adipose banking guide explains the basics. The table below sets both options side by side, using only what FDA and the federal rule state.
| Question | Cord blood banking | Adipose tissue banking |
|---|---|---|
| When can it happen? | At birth, from the umbilical cord | As an adult, from tissue removed from your own body |
| What cells are involved? | Hematopoietic progenitor cells, which form blood | Adipose tissue, from which mesenchymal stromal cells are studied |
| Regulatory status of stored material | Private use units need no FDA approval before use; banks must register, list, screen, test and follow good tissue practice; unrelated donor units need a BLA or IND | Autologous use requires no donor eligibility determination under 21 CFR 1271.90; tissue is labeled “FOR AUTOLOGOUS USE ONLY” |
| FDA licensed products | Nine HPC, Cord Blood products, all for unrelated donor transplantation | None |
Cord blood has licensed products with a defined indication, and adipose tissue has none. That is the honest starting point for any adult comparing the two.
How Should You Think About the Comparison Honestly?
Think about Cord Blood vs Adipose as two different decisions with two different evidence records, not as a contest that adipose banking wins because it is available to adults. We found no published source comparing the two as services.
For private cord blood, the published record is candid about use. The American Academy of Pediatrics stated in its 2017 policy statement that private units are “underused for treatment” and that “the unit may never be used.” A 2009 decision model assumed a 0.04 percent chance that a child would require an autologous transplant and 0.07 percent for a sibling, and said patients considering private banking “should be informed of the remote likelihood that a unit will be used” (Kaimal 2009).
For adipose tissue, no comparable figure exists. We found nothing published on the likelihood that banked adipose tissue is ever used, so this post states no number. The cord blood figures are modeled estimates about blood forming cells and do not transfer to adipose tissue. Our post on banking for families covers household decisions.
Instead of relying on comparisons, ask a bank how the tissue is labeled, what records accompany it, and what the storage agreement says about release.
Frequently Asked Questions
Did I miss my chance by not banking cord blood?
You cannot bank your own cord blood as an adult, because FDA describes collection as taking place from the umbilical cord at birth. Adipose tissue banking is a separate option that preserves your own tissue. It does not replace cord blood or offer the same cells.
Is adipose banking the adult version of cord blood banking?
No. Cord blood holds blood forming cells with nine FDA licensed products for unrelated donor transplantation. Adipose research centers on mesenchymal stromal cells, and no adipose-derived product has FDA approval.
Is there an FDA approved adipose-derived stem cell product?
No. Ryoncil, approved on December 18, 2024 for a pediatric graft versus host disease indication, is allogeneic and bone marrow derived. Bone marrow and cord blood results do not validate adipose tissue.
Does banking adipose tissue give me access to a future therapy?
No. Banking preserves your own tissue under the autologous labeling rules in 21 CFR 1271.90. It does not guarantee eligibility, access, or clinical benefit from any future therapy, trial, or program.
Key Takeaways
Cord blood banking happens once, at birth, and stores blood forming cells, and its nine FDA licensed products are for unrelated donor transplantation. Adipose tissue banking is available to adults and preserves autologous tissue whose mesenchymal stromal cells are studied for different purposes, with no FDA approved adipose-derived product. The AAP calls private cord blood units underused, and no published figure exists for banked adipose tissue. Banking adipose tissue does not guarantee eligibility, access, or clinical benefit from any future therapy.
Save My Fat connects patients and providers with a U.S.-based tissue bank. It is not a tissue bank, a laboratory, a medical practice, or a treatment provider. Stem cell and regenerative medicine regulations vary by state, including specific informed-consent and disclosure requirements in Florida, Utah, California, Georgia, and Tennessee governing tissue and stem cell services. Banking adipose tissue does not connect patients to any treatment pathway, and any future use depends on FDA regulatory status, physician guidance, and the availability of approved or investigational pathways at that time.
Adults weighing adipose tissue banking for potential future use can review current pricing or bring their cord blood questions to the contact page.
Save My Fat works with a U.S.-based tissue bank for laboratory processing and storage.
This article is for educational purposes only and does not constitute medical or legal advice. Please consult your hematologist before making any decisions about blood or immune treatment or research participation.
About the author: Oscar Tellez is the founder and CEO of Save My Fat. He holds a Bachelor of Science in Exercise Science and Health Promotion from Florida Atlantic University. He has spent a decade in the regenerative medicine industry across product distribution, laboratory and vendor relationships, and provider training. He is not a licensed clinician, and this article is educational, not medical advice.
Related guide: the stem cell science glossary.
